Aravis leads Series B financing in Evolva SA Totalling CHF 44 M followed by a reverse merger of Evolva with Arpida
16-Dec-2009
- Switzerland
Aravis first invested in Evolva SA when the fund led a CHF 21.8 M (USD 21.1 M) Series A round in August 2004/5. At that time Aravis was also instrumental in moving Evolva to Allschwil (Basel) in Switzerland. Aravis then went on to lead a second closing of this Series A to the value of CHF 12 M (USD 10.3 M) in December 2006.
Most read news
Other news from the department business & finance
Get the life science industry in your inbox
From now on, don't miss a thing: Our newsletter for biotechnology, pharma and life sciences brings you up to date every Tuesday and Thursday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.